Published: 2017-07-20

Clinical profile of patients undergoing coronary angiography with special reference to complications of coronary angiography

Lumb Raghav, Parag Waghmode, Parkar Matin A., Shubhadarshini Pawar


Background: Cardiovascular Diseases (CVD’s) remain the biggest cause of death worldwide. Recent trends suggest that disease incidence has escalated and has started affecting younger age group also. Incidence of CVD’s has been on increasing trend not only in urban areas but in rural areas also. Aim of this research is to study clinical profile and complications in patients undergoing coronary angiography.

Methods: 100 patients admitted in hospital who were planned for coronary angiography were selected. All routine investigations, Hba1c if patient is known diabetic, Serology, ECG, CXR were done at the time of admission. General physical and local examinations were performed at the end of procedure, after 12, 48 and 72 hours of coronary angiography.

Results: Acute Myocardial Infarction (AMI) is the commonest indication for CAG in this study group. Out of 100 patients who underwent CAG, complications occurred in 29 individuals. Only 3 types of complications- Haematoma, Anaphylactoid reactions and Contrast Induced Nephropathy (CIN) are observed in this study.

Conclusions: Hypertension, obesity, family history of IHD in first degree relatives and DM are important risk factors for IHD. Most common complication of CAG is haematoma. Females patients are more predisposed for all complications DM, HTN, advanced age and CHF are independent risk factors for developing CIN.


Angiography, Cardiovascular diseases, Haematoma, IHD

Full Text:



Chauhan S, Taeri B. Prevalence of Cardiovascular disease in India and its economic impact- a review: Int J Sci Res Pub. 2013;3(10):1-5.

Mendis S, Puska P, Norrving B. Global Atlas on Cardiovascular disease prevention and Control. World Health Organization Geneva 2011.

Fan AZ, Russel M, Stranges S, Dorn J, Trevisan M. Association of lifetime alcohol drinking trajectories with cardiometabolic risk. J Clin Endocrinol Metabol USA. 2008;93(1):154-61.

Who expert consultation. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. The Lancet. 2004;363(9403):157-63.

Gupta R, Rastogi P, Sarna M, Gupta VP, Sharma SK, Kothari K. Body-Mass Index, Waist-size, Waist-Hip Ratio and Cardiovascular Risk Factors in Urban Subjects. J Asso Physician Ind. 2007;55:621-7.

Chen Y, Copland WK, Vedanthan R, Grant E, Lee JE, Gu D, et al. Association between Body-Mass Index and cardiovascular disease mortality in east and south Asians: A pooled analysis of prospective data from the Asia cohort consortium. British Med J. 2013;347:f5446.

Jousilahti P, Vartianen T, Tuomilehto J, Pushka P. Sex, age, cardiovascular risk factors, and coronary heart disease; American Heart Association: A prospective and follow up study of 14786 middle aged men and women in Finland. Cir. 1999;99:1165-72.

James B Meigs, Peter WF Wilson. Body Mass Index, metabolic syndrome and risk of type 2 diabetes or cardiovascular disease: J Clin Endocrinol Metabol USA. 2006;(91):2906-12.

Calle EE, Thun MJ, Petrelli JM. Body-Mass index and mortality in a Prospective cohort of U.S. adults; New Eng J Med. 1999;7(341)(15):1097-105.

Wajih-ur-Rehman, Hameed S, Naveed T. Bleeding in patients undergoing percutaneous coronary intervention. Pak J Med Sc. 2011;27(5):958-62.

Dauerman HL, Rao SV, Resnic FS. Bleeding Avoidance Strategies: consensus and controversy. J Am College Cardiol. 2011;58(1):1-10.

Wimmer NJ, Resnic FS, Mauri L. Risk-treatment paradox in the selection of trans radial access for percutaneous coronary intervention. J Am Heart Assoc. 2013;2:e000174.

Ahmed B, Dauerman HL. Women bleeding and coronary intervention; Am Heart Assoc, Cir. 2013;127:641-9.

Chiu JH, Bhatt DL, Ziada KM, Chew DP, Whitlow PL, Lincoff AM, et al. Impact of female sex on outcome after percutaneous coronary intervention. Am Heart J. 2004;148(6):998-1002.

Sallam M, Al-Hadi H, Chandy S. Comparative study of radial and femoral artery approaches for diagnostic coronary angiography. Sultan Qaboos Univ Med J. 2009;9(3):272-8.

Tewari S, Sharma N, Kapoor A, Syal SK, Kumar S, Garg N, et al. Comparison of transradial and transfemoral artery approach for percutaneous coronary angiography and angioplasty: A retrospective seven-year experience from a north Indian centre. Ind Heart J. 2013;65(4):378-87.

Hess CN, Peterson ED, Neely ML. Learning curve for transradial percutaneous coronary intervention among operators in United States; Am Heart Association, Cir. 2014;129(22):2277-86.

Nayak KR, White AA, Cavendish JJ. Anaphylactoid reactions to radiocontrast agents: prevention and treatment in the cardiac catheterization laboratory. J Invasive Cardiol. 2009;21:548-51.

Goss JE, Chambers CE, Heupler FA JR. Systemic anaphylactoid reactions to iodinated contrast media during cardiac catheterization procedures. J Catheterization Cardiovascular Intervention. 1995;34:99-104.

Rear R, Bell RM, Hausenloy DJ. Contrast induced nephropathy following angiography and cardiac interventions. BMJ Heart. 2016;102:638-48.

Murphy SW, Barrett BJ, Parfrey PS. Contrast Nephropathy. J Am Soc Nephrol. 2000;11:177-82.

Bartholomew BA, Harjai KJ, Dukkipati S. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93:1515-9.

Mehran R, Aymong ED, Nikolsky E. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393-9.

Marenzi G, Lauri G, Assanelli E. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44:1780-5.